Hybrid On-Offline Event Scheduled for the 9th of Next Month

Exterior view of Samsung Seoul Hospital. [Photo by Samsung Seoul Hospital]

Exterior view of Samsung Seoul Hospital. [Photo by Samsung Seoul Hospital]

View original image

[Asia Economy Reporter Lee Gwan-joo] Samsung Seoul Hospital's Smart Healthcare Research Institute and Digital Therapeutics Research Center announced on the 29th that they will hold the "2nd International Symposium" in a hybrid format of online and offline on the 9th of next month.


The symposium will be attended by Adam Gazali, founder of Akili Interactive, virtual reality (VR) expert Professor An Seon-joo from the University of Georgia, Robert Reike, Chief Technology Officer of Medtronic USA, Hwang Hee, CEO of Kakao Healthcare, Lim Jin-hwan, CEO of Aimmed, and Bin Jun-gil, CEO of Neurofit.


In addition, startup companies from Samsung Seoul Hospital, as well as researchers from Samsung Seoul Hospital and Wonju Severance Christian Hospital, will share the latest research and development (R&D) trends. The Korea Health Industry Development Institute will also cover topics such as regulatory approval for innovative medical devices and insurance fee strategies, focusing on practical application in medical fields and market entry.



Choi Dong-il, director of the Smart Healthcare Research Institute (Professor of Radiology), and Jeon Hong-jin, director of the Digital Therapeutics Research Center (Professor of Psychiatry), stated, "Through this symposium, we hope to have an active exchange of knowledge and communication in the field of digital and electronic therapeutic devices both domestically and internationally, and that it will be a meaningful opportunity for the development of related industries in Korea and global growth." They added, "It will help grasp the major trends in preparing for future healthcare in the era of digital transformation in medicine."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing